Skip to main content
SpringerLink
Log in

Cognitive Impairment in the Pre-Transplant Setting

  • Chapter
  • First Online:
Transplant Psychiatry

  • 343 Accesses

Abstract

Patients with chronic and complex medical conditions, such as those who present for pre-transplant psychiatric evaluations, are at increased risk for cognitive impairment (CI). The medical and psychiatric comorbidities with which they present and some of the treatments they are prescribed can contribute to such impairment, which is not always easily detected during a routine evaluation. Since CI is associated with decreased adherence with pre- and post-transplant treatment recommendations and poor outcomes, the transplant psychiatrist needs to determine the severity of such impairment and whether it is an obstacle to the listing. If the CI is not a contraindication to listing, a management approach that will either limit further cognitive decline or result in improvements in cognition ought to be considered. In assisting with this goal, the transplant psychiatrist will contribute to the selection of appropriate candidates who are likely to benefit from transplant surgery.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. United States Renal Data System. 2019 annual data report: atlas of chronic kidney disease and end-stage Rena; disease in the United States. Bethesda: National Institute of Diabetes and Digestive and Kidney Diseases; 2019.

    Google Scholar 

  2. Vanderlinden JA, Ross-White A, Holden R, Shamseddin MK, Day A, Boyd JG. Quantifying cognitive dysfunction across the spectrum of end-stage kidney disease: a systematic review and meta-analysis. Nephrology (Carlton). 2019;24(1):5–16.

    Article  Google Scholar 

  3. Brodski J, Rossell SL, Castle DJ, Tan EJ. A systematic review of cognitive impairments associated with kidney failure in adults before natural age-related changes. J Int Neuropsychol Soc. 2019;25(1):101–14.

    Article  Google Scholar 

  4. Kurella M, Chertow GM, Fried LF, Cummings SR, Harris T, Simonsick E, Satterfield S, Ayonayon H, Yaffe K. Chronic kidney disease and cognitive impairment in the elderly: the health, aging, and body composition study. J Am Soc Nephrol. 2005;16(7):2127–33.

    Article  Google Scholar 

  5. Yaffe K, Ackerson L, Kurella Tamura M, Le Blanc P, Kusek JW, Sehgal AR, Cohen D, Anderson C, Appel L, Desalvo K, Ojo A, Seliger S, Robinson N, Makos G, Go AS. Chronic renal insufficiency cohort investigators. Chronic kidney disease and cognitive function in older adults: findings from the chronic renal insufficiency cohort cognitive study. J Am Geriatr Soc. 2010;58(2):338–45.

    Article  Google Scholar 

  6. Anand S, Johansen KL, Kurella TM. Aging and chronic kidney disease: the impact on physical function and cognition. J Gerontol A Biol Sci Med Sci. 2014;69(3):315–22.

    Article  Google Scholar 

  7. Murray AM, Bell EJ, Tupper DE, Davey CS, Pederson SL, Amiot EM, Miley KM, McPherson L, Heubner BM, Gilbertson DT, Foley RN, Drawz PE, Slinin Y, Rossom RC, Lakshminarayan K, Vemuri P, Jack CR, Knopman DS. The brain in kidney disease (BRINK) cohort study: design and baseline cognitive function. Am J Kidney Dis. 2016;67(4):593–600.

    Article  Google Scholar 

  8. Weiner DE, Gaussoin SA, Nord J, Auchus AP, Chelune GJ, Chonchol M, Coker L, Haley WE, Killeen AA, Kimmel PL, Lerner AJ, Oparil S, Saklayen MG, Slinin YM, Wright CB, Williamson JD, Kurella Tamura M, SPRINT Study Research Group. Cognitive function and kidney disease: baseline data from the systolic blood pressure intervention trial (SPRINT). Am J Kidney Dis. 2017;70(3):357–67.

    Article  Google Scholar 

  9. Berger I, Wu S, Masson P, Kelly PJ, Duthie FA, Whiteley W, Parker D, Gillespie D, Webster AC. Cognition in chronic kidney disease: a systematic review and meta-analysis. BMC Med. 2016;14(1):206.

    Article  Google Scholar 

  10. Yaffe K, Ackerson L, Kurella Tamura M, Le Blanc P, Kusek JW, Sehgal AR, et al. Chronic renal insufficiency cohort investigators. Chronic kidney disease and cognitive function in older adults: findings from the chronic renal insufficiency cohort cognitive study. J Am Geriatr Soc. 2010;58(2):338–45.

    Article  Google Scholar 

  11. Sarnak MJ, Tighiouart H, Scott TM, Lou KV, Sorensen EP, Giang LM, et al. Frequency of and risk factors for poor cognitive performance in hemodialysis patients. Neurology. 2013;80(5):471–80.

    Article  Google Scholar 

  12. Kalirao P, Pederson S, Foley RN, Kolste A, Tupper D, Zaun D, Buot V, Murray AM. Cognitive impairment in peritoneal dialysis patients. Am J Kidney Dis. 2011;57(4):612–20.

    Article  Google Scholar 

  13. Kurella Tamura M, Yaffe K. Dementia and cognitive impairment in ESRD: diagnostic and therapeutic strategies. Kidney Int. 2011;79(1):14–22.

    Article  Google Scholar 

  14. Murray AM, Tupper DE, Knopman DS, Gilbertson DT, Pederson SL, Li S, et al. Cognitive impairment in hemodialysis patients is common. Neurology. 2006;67(2):216–23.

    Article  CAS  Google Scholar 

  15. Drew DA, Weiner DE, Tighiouart H, Duncan S, Gupta A, Scott T, Sarnak MJ. Cognitive decline and its risk factors in prevalent Hemodialysis patients. Am J Kidney Dis. 2017;69(6):780–7.

    Article  Google Scholar 

  16. Kurella Tamura M, Vittinghoff E, Hsu CY, Tam K, Seliger SL, Sozio S, Fischer M, Chen J, Lustigova E, Strauss L, Deo R, Go AS, Yaffe K, CRIC Study Investigators. Loss of executive function after dialysis initiation in adults with chronic kidney disease. Kidney Int. 2017;91(4):948–53.

    Article  Google Scholar 

  17. McAdams-DeMarco MA, Tan J, Salter ML, Gross A, Meoni LA, Jaar BG, Kao WH, Parekh RS, Segev DL, Sozio SM. Frailty and cognitive function in incident Hemodialysis patients. Clin J Am Soc Nephrol. 2015;10(12):2181–9.

    Article  Google Scholar 

  18. O'Lone E, Connors M, Masson P, Wu S, Kelly PJ, Gillespie D, et al. Cognition in people with end-stage kidney disease treated with hemodialysis: a systematic review and meta-analysis. Am J Kidney Dis. 2016;67(6):925–35.

    Article  Google Scholar 

  19. Kurella Tamura M, Wadley V, Yaffe K, McClure LA, Howard G, Go R, Allman RM, Warnock DG, McClellan W. Kidney function and cognitive impairment in US adults: the reasons for geographic and racial differences in stroke (REGARDS) study. Am J Kidney Dis. 2008;52(2):227–34.

    Article  Google Scholar 

  20. Buchman AS, Tanne D, Boyle PA, Shah RC, Leurgans SE, Bennett DA. Kidney function is associated with the rate of cognitive decline in the elderly. Neurology. 2009;73(12):920–7.

    Article  Google Scholar 

  21. Elias MF, Elias PK, Seliger SL, Narsipur SS, Dore GA, Robbins MA. Chronic kidney disease, creatinine and cognitive functioning. Nephrol Dial Transplant. 2009;24(8):2446–52.

    Article  CAS  Google Scholar 

  22. Harciarek M, Williamson JB, Biedunkiewicz B, Lichodziejewska-Niemierko M, Dębska-Ślizień A, Rutkowski B. Risk factors for selective cognitive decline in dialyzed patients with end-stage renal disease: evidence from verbal fluency analysis. J Int Neuropsychol Soc. 2012;18(1):162–7.

    Article  Google Scholar 

  23. Altmann P, Barnett ME, Finn WF, SPD405-307 Lanthanum Carbonate Study Group. Cognitive function in stage 5 chronic kidney disease patients on hemodialysis: no adverse effects of lanthanum carbonate compared with standard phosphate-binder therapy. Kidney Int. 2007;71(3):252–9.

    Article  CAS  Google Scholar 

  24. Zhang YH, Yang ZK, Wang JW, Xiong ZY, Liao JL, Hao L, Liu GL, Ren YP, Wang Q, Duan LP, Zheng ZX, Dong J. Cognitive changes in peritoneal dialysis patients: a multicenter prospective cohort study. Am J Kidney Dis. 2018;72(5):691–700.

    Article  Google Scholar 

  25. Cheung AK, Sarnak MJ, Yan G, Dwyer JT, Heyka RJ, Rocco MV, et al. Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int. 2000;58(1):353–62.

    Article  CAS  Google Scholar 

  26. Cheung AK, Sarnak MJ, Yan G, Berkoben M, Heyka R, Kaufman A, et al. Cardiac diseases in maintenance hemodialysis patients: results of the HEMO study. Kidney Int. 2004;65(6):2380–9.

    Article  Google Scholar 

  27. Seliger SL, Gillen DL, Longstreth WT Jr, Kestenbaum B, Stehman-Breen CO. Elevated risk of stroke among patients with end-stage renal disease. Kidney Int. 2003;64(2):603–9.

    Article  Google Scholar 

  28. Drew DA, Bhadelia R, Tighiouart H, Novak V, Scott TM, Lou KV, et al. Anatomic brain disease in hemodialysis patients: a cross-sectional study. Am J Kidney Dis. 2013;61(2):271–8.

    Article  Google Scholar 

  29. Power A, Chan K, Singh SK, Taube D, Duncan N. Appraising stroke risk in maintenance hemodialysis patients: a large single-center cohort study. Am J Kidney Dis. 2012;59(2):249–57.

    Article  Google Scholar 

  30. Murray AM, Seliger S, Lakshminarayan K, Herzog CA, Solid CA. Incidence of stroke before and after dialysis initiation in older patients. J Am Soc Nephrol. 2013;24(7):1166–73.

    Article  Google Scholar 

  31. Toyoda K, Fujii K, Fujimi S, Kumai Y, Tsuchimochi H, Ibayashi S, Iida M. Stroke in patients on maintenance hemodialysis: a 22-year single-center study. Am J Kidney Dis. 2005;45(6):1058–66.

    Article  Google Scholar 

  32. Findlay M, MacIsaac R, MacLeod MJ, Metcalfe W, Traynor JP, Dawson J, Mark PB. Renal replacement modality and stroke risk in end-stage renal disease-a national registry study. Nephrol Dial Transplant. 2018;33(9):1564–71.

    CAS  Google Scholar 

  33. Daugirdas JT. Pathophysiology of dialysis hypotension: an update. Am J Kidney Dis. 2001;38(4 Suppl 4):S11–7.

    Article  CAS  Google Scholar 

  34. MacEwen C, Sutherland S, Daly J, Pugh C, Tarassenko L. Relationship between hypotension and cerebral ischemia during Hemodialysis. J Am Soc Nephrol. 2017;28(8):2511–20.

    Article  CAS  Google Scholar 

  35. Polinder-Bos HA, García DV, Kuipers J, Elting JWJ, Aries MJH, Krijnen WP, et al. Hemodialysis induces an acute decline in cerebral blood flow in elderly patients. J Am Soc Nephrol. 2018;29(4):1317–25.

    Article  CAS  Google Scholar 

  36. Findlay MD, Dawson J, Dickie DA, Forbes KP, McGlynn D, Quinn T, et al. Investigating the relationship between cerebral blood flow and cognitive function in Hemodialysis patients. J Am Soc Nephrol. 2019;30(1):147–58.

    Article  Google Scholar 

  37. Mizumasa T, Hirakata H, Yoshimitsu T, Hirakata E, Kubo M, Kashiwagi M, et al. Dialysis-related hypotension as a cause of progressive frontal lobe atrophy in chronic hemodialysis patients: a 3-year prospective study. Nephron Clin Pract. 2004;97(1):c23–30.

    Article  Google Scholar 

  38. McIntyre CW. Recurrent circulatory stress: the dark side of dialysis. Semin Dial. 2010;23(5):449–51.

    Article  Google Scholar 

  39. Watanabe A. Cerebral microbleeds and intracerebral hemorrhages in patients on maintenance hemodialysis. J Stroke Cerebrovasc Dis. 2007;16(1):30–3.

    Article  Google Scholar 

  40. Joshee P, Wood AG, Wood ER, Grunfeld EA. Meta-analysis of cognitive functioning in patients following kidney transplantation. Nephrol Dial Transplant. 2018;33(7):1268–77.

    Article  CAS  Google Scholar 

  41. Van Sandwijk MS, Ten Berge IJ, Majoie CB, Caan MW, De Sonneville LM, Van Gool WA, et al. Cognitive changes in chronic kidney disease and after transplantation. Transplantation. 2016;100(4):734–42.

    Article  Google Scholar 

  42. Drew DA, Weiner DE, Tighiouart H, Scott T, Lou K, Kantor A, Fan L, Strom JA, Singh AK, Sarnak MJ. Cognitive function and all-cause mortality in maintenance hemodialysis patients. Am J Kidney Dis. 2015;65(2):303–11.

    Article  Google Scholar 

  43. Iyasere O, Brown EA. Cognitive function before and after dialysis initiation in adults with chronic kidney disease-a new perspective on an old problem? Kidney Int. 2017;91(4):784–6.

    Article  Google Scholar 

  44. da Matta SM, Janaina Matos M, Kummer AM, Barbosa IG, Teixeira AL, Silva AC. Cognitive alterations in chronic kidney disease: an update. J Bras Nefrol. 2014;36(2):241–5.

    Article  Google Scholar 

  45. Hermann DM, Kribben A, Bruck H. Cognitive impairment in chronic kidney disease: clinical findings, risk factors and consequences for patient care. J Neural Transm (Vienna). 2014;121(6):627–32.

    Article  Google Scholar 

  46. Kurella M, Mapes DL, Port FK, Chertow GM. Correlates and outcomes of dementia among dialysis patients: the dialysis outcomes and practice patterns study. Nephrol Dial Transplant. 2006;21(9):2543–8.

    Article  Google Scholar 

  47. Kallenberg MH, Kleinveld HA, Dekker FW, van Munster BC, Rabelink TJ, van Buren M, Mooijaart SP. Functional and cognitive impairment, frailty, and adverse health outcomes in older patients reaching ESRD-A systematic review. Clin J Am Soc Nephrol. 2016;11(9):1624–39.

    Article  Google Scholar 

  48. Griva K, Stygall J, Hankins M, Davenport A, Harrison M, Newman SP. Cognitive impairment and 7-year mortality in dialysis patients. Am J Kidney Dis. 2010;56(4):693–703.

    Article  Google Scholar 

  49. Bhushan C, Haldar JP, Choi S, Joshi AA, Shattuck DW, Leahy RM. Co-registration and distortion correction of diffusion and anatomical images based on inverse contrast normalization. NeuroImage. 2015;115:269–80.

    Article  Google Scholar 

  50. Findlay MD, Donaldson K, Doyle A, Fox JG, Khan I, McDonald J, Metcalfe W, Peel RK, Shilliday I, Spalding E, Stewart GA, Traynor JP, Mackinnon B, Scottish Renal Registry (SRR). Factors influencing withdrawal from dialysis: a national registry study. Nephrol Dial Transplant. 2016;31(12):2041–8.

    Article  Google Scholar 

  51. Weiner DE, Scott TM, Giang LM, Agganis BT, Sorensen EP, Tighiouart H, Sarnak MJ. Cardiovascular disease and cognitive function in maintenance hemodialysis patients. Am J Kidney Dis. 2011;58(5):773–81.

    Article  Google Scholar 

  52. Kurella Tamura M, Larive B, Unruh ML, Stokes JB, Nissenson A, Mehta RL, et al. Prevalence and correlates of cognitive impairment in hemodialysis patients: the frequent Hemodialysis network trials. Clin J Am Soc Nephrol. 2010;5(8):1429–38.

    Article  Google Scholar 

  53. Sánchez-Fernández MDM, Reyes Del Paso GA, Gil-Cunquero JM, Fernández-Serrano MJ. Executive function in end-stage renal disease: acute effects of hemodialysis and associations with clinical factors. PLoS One. 2018;13(9):e0203424.

    Article  Google Scholar 

  54. Gupta A, Montgomery RN, Bedros V, Lesko J, Mahnken JD, Chakraborty S, Drew D, Klein JA, Thomas TS, Ilahe A, Budhiraja P, Brooks WM, Schmitt TM, Sarnak MJ, Burns JM, Cibrik DM. Subclinical cognitive impairment and listing for kidney transplantation. Clin J Am Soc Nephrol. 2019;14(4):567–75.

    Article  Google Scholar 

  55. Barzilay JI, Gao P, O'Donnell M, Mann JF, Anderson C, Fagard R, et al. Albuminuria and decline in cognitive function: the ONTARGET/TRANSCEND studies. Arch Intern Med. 2011;171(2):142–50.

    Article  Google Scholar 

  56. SPRINT MIND Investigators for the SPRINT Research Group, Williamson JD, Pajewski NM, Auchus AP, Bryan RN, Chelune G, Cheung AK, Cleveland ML, Coker LH, Crowe MG, Cushman WC, Cutler JA, Davatzikos C, Desiderio L, Erus G, Fine LJ, Gaussoin SA, Harris D, Hsieh MK, Johnson KC, Kimmel PL, Tamura MK, Launer LJ, Lerner AJ, Lewis CE, Martindale-Adams J, Moy CS, Nasrallah IM, Nichols LO, Oparil S, Ogrocki PK, Rahman M, Rapp SR, Reboussin DM, Rocco MV, Sachs BC, Sink KM, Still CH, Supiano MA, Snyder JK, Wadley VG, Walker J, Weiner DE, Whelton PK, Wilson VM, Woolard N, Wright JT Jr, Wright CB. Effect of intensive vs standard blood pressure control on probable dementia: a randomized clinical trial. JAMA. 2019;321(6):553–61.

    Article  Google Scholar 

  57. Baggetta R, D'Arrigo G, Torino C, ElHafeez SA, Manfredini F, Mallamaci F, Zoccali C, Tripepi G, EXCITE Working Group. Effect of a home based, low intensity, physical exercise program in older adults dialysis patients: a secondary analysis of the EXCITE trial. BMC Geriatr. 2018;18(1):248.

    Article  Google Scholar 

  58. McAdams-DeMarco MA, Konel J, Warsame F, Ying H, González Fernández M, Carlson MC, Fine DM, Appel LJ, Segev DL. Intradialytic cognitive and exercise training may preserve cognitive function. Kidney Int Rep. 2017;3(1):81–8.

    Article  Google Scholar 

  59. Stringuetta Belik F, Oliveira E, Silva VR, Braga GP, Bazan R, Perez Vogt B, Costa Teixeira Caramori J, Barretti P, de Souza Gonçalves R, Fortes Villas Bôas PJ, Hueb JC, Martin LC, da Silva Franco RJ. Influence of intradialytic aerobic training in cerebral blood flow and cognitive function in patients with chronic kidney disease: a pilot randomized controlled trial. Nephron. 2018;140(1):9–17.

    Article  Google Scholar 

  60. Campagna F, Montagnese S, Schiff S, Biancardi A, Mapelli D, Angeli P, Poci C, Cillo U, Merkel C, Gatta A, Amodio P. Cognitive impairment and electroencephalographic alterations before and after liver transplantation: what is reversible? Liver Transpl. 2014;20(8):977–86.

    Article  Google Scholar 

  61. Fichet J, Mercier E, Genée O, Garot D, Legras A, Dequin PF, Perrotin D. Prognosis and 1-year mortality of intensive care unit patients with severe hepatic encephalopathy. J Crit Care. 2009;24(3):364–70.

    Article  CAS  Google Scholar 

  62. Bernardin F, Maheut-Bosser A, Paille F. Cognitive impairments in alcohol-dependent subjects. Front Psych. 2014;5:78.

    Google Scholar 

  63. Bocarsly ME, Fasolino M, Kane GA, LaMarca EA, Kirschen GW, Karatsoreos IN, McEwen BS, Gould E. Obesity diminishes synaptic markers, alters microglial morphology, and impairs cognitive function. Proc Natl Acad Sci U S A. 2015;112(51):15731–6.

    Article  CAS  Google Scholar 

  64. McAndrews MP, Farcnik K, Carlen P, Damyanovich A, Mrkonjic M, Jones S, Heathcote EJ. Prevalence and significance of neurocognitive dysfunction in hepatitis C in the absence of correlated risk factors. Hepatology. 2005;41(4):801–8.

    Article  Google Scholar 

  65. Streisand RM, Rodrigue JR, Sears SF Jr, Perri MG, Davis GL, Banko CG. A psychometric normative database for pre-liver transplantation evaluations. The Florida cohort 1991–1996. Psychosomatics. 1999;40(6):479–85.

    Article  CAS  Google Scholar 

  66. McCrea M, Cordoba J, Vessey G, Blei AT, Randolph C. Neuropsychological characterization and detection of subclinical hepatic encephalopathy. Arch Neurol. 1996;53(8):758–63.

    Article  CAS  Google Scholar 

  67. Blei AT. Hepatic encephalopathy. In: Bircher J, Benhamou JP, McIntyre N, et al., editors. Oxford textbook of clinical hepatology. Oxford: Oxford University Press; 1999. p. 765–83.

    Google Scholar 

  68. Weissenborn K, Ennen JC, Schomerus H, Rückert N, Hecker H. Neuropsychological characterization of hepatic encephalopathy. J Hepatol. 2001;34(5):768–73.

    Article  CAS  Google Scholar 

  69. Schiff S, Vallesi A, Mapelli D, Orsato R, Pellegrini A, Umiltà C, Gatta A, Amodio P. Impairment of response inhibition precedes motor alteration in the early stage of liver cirrhosis: a behavioral and electrophysiological study. Metab Brain Dis. 2005;20(4):381–92.

    Article  Google Scholar 

  70. Sorrell JH, Zolnikov BJ, Sharma A, Jinnai I. Cognitive impairment in people diagnosed with end-stage liver disease evaluated for liver transplantation. Psychiatry Clin Neurosci. 2006;60(2):174–81.

    Article  Google Scholar 

  71. Bajaj JS, Saeian K, Verber MD, Hischke D, Hoffmann RG, Franco J, Varma RR, Rao SM. Inhibitory control test is a simple method to diagnose minimal hepatic encephalopathy and predict development of overt hepatic encephalopathy. Am J Gastroenterol. 2007;102(4):754–60.

    Article  Google Scholar 

  72. Forton DM, Thomas HC, Murphy CA, Allsop JM, Foster GR, Main J, Wesnes KA, Taylor-Robinson SD. Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease. Hepatology. 2002;35(2):433–9.

    Article  Google Scholar 

  73. Hilsabeck RC, Perry W, Hassanein TI. Neuropsychological impairment in patients with chronic hepatitis C. Hepatology. 2002;35(2):440–6.

    Article  Google Scholar 

  74. Romero-Gomez M, Boza F, Garcia-Valdecasas MS, Garcia E, Aguilar-Reina J. Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy. Am J Gastroenterol. 2001;96:2718–23.

    Article  CAS  Google Scholar 

  75. Poordad FF. Review article: the burden of hepatic encephalopathy. Aliment Pharmacol Ther. 2007;25(Suppl 1):3–9.

    Article  Google Scholar 

  76. Amodio P, Del Piccolo F, Marchetti P, Angeli P, Iemmolo R, Caregaro L, Merkel C, Gerunda G, Gatta A. Clinical features and survivial of cirrhotic patients with subclinical cognitive alterations detected by the number connection test and computerized psychometric tests. Hepatology. 1999;29(6):1662–7.

    Article  CAS  Google Scholar 

  77. Dhiman RK, Kurmi R, Thumburu KK, Venkataramarao SH, Agarwal R, Duseja A, Chawla Y. Diagnosis and prognostic significance of minimal hepatic encephalopathy in patients with cirrhosis of liver. Dig Dis Sci. 2010;55(8):2381–90.

    Article  Google Scholar 

  78. Ampuero J, Simon M, Montoliu C, Jover R, Serra MA, Cordoba J, Romero-Gomez M. Minimal hepatic encephalopathy and critical flicker frequency are associated with survival of patients with cirrhosis. Gastroenterology. 2015;149:1483–9.

    Article  Google Scholar 

  79. Hartmann IJ, Groeneweg M, Quero JC, Beijeman SJ, de Man RA, Hop WC, Schalm SW. The prognostic significance of subclinical hepatic encephalopathy. Am J Gastroenterol. 2000;95(8):2029–34.

    Article  CAS  Google Scholar 

  80. Bajaj JS, Schubert CM, Heuman DM, Wade JB, Gibson DP, Topaz A, et al. Persistence of cognitive impairment after resolution of overt hepatic encephalopathy. Gastroenterology. 2010;138(7):2332–40.

    Article  Google Scholar 

  81. Garcia-Martinez R, Rovira A, Alonso J, Jacas C, Simón-Talero M, Chavarria L, Vargas V, Córdoba J. Hepatic encephalopathy is associated with posttransplant cognitive function and brain volume. Liver Transpl. 2011;17(1):38–46.

    Article  Google Scholar 

  82. Wein C, Koch H, Popp B, Oehler G, Schauder P. Minimal hepatic encephalopathy impairs fitness to drive. Hepatology. 2004;39:739–45.

    Article  Google Scholar 

  83. Bajaj JS, Saeian K, Hafeezullah M, Hoffmann RG, Hammeke TA. Patients with minimal hepatic encephalopathy have poor insight into their driving skills. Clin Gastroenterol Hepatol. 2008;6(10):1135–9. quiz 1065

    Article  Google Scholar 

  84. Bajaj JS, Saeian K, Schubert CM, Hafeezullah M, Franco J, Varma RR, Gibson DP, Hoffmann RG, Stravitz RT, Heuman DM, Sterling RK, Shiffman M, Topaz A, Boyett S, Bell D, Sanyal AJ. Minimal hepatic encephalopathy is associated with motor vehicle crashes: the reality beyond the driving test. Hepatology. 2009;50(4):1175–83.

    Article  Google Scholar 

  85. Kim Y, Park G, Lee M, Lee JH. Impairment of driving ability and neuropsychological function in patients with MHE disease. Cyberpsychol Behav. 2009;12(4):433–6.

    Article  Google Scholar 

  86. Gad YZ, Zaher AA, Moussa NH, El-desoky AE, Al-Adarosy HA. Screening for minimal hepatic encephalopathy in asymptomatic drivers with liver cirrhosis. Arab J Gastroenterol. 2011;12(2):58–61. Epub 2011 Jun 12. PMID: 21684474

    Article  Google Scholar 

  87. Roman E, Cordoba J, Torrens M, Torras X, Villanueva C, Vargas V, Guarner C, et al. Minimal hepatic encephalopathy is associated with falls. Am J Gastroenterol. 2011;106:476–82.

    Article  Google Scholar 

  88. Soriano G, Román E, Córdoba J, Torrens M, Poca M, Torras X, Villanueva C, Gich IJ, Vargas V, Guarner C. Cognitive dysfunction in cirrhosis is associated with falls: a prospective study. Hepatology. 2012;55(6):1922–30.

    Article  Google Scholar 

  89. Córdoba J, Cabrera J, Lataif L, Penev P, Zee P, Blei AT. High prevalence of sleep disturbance in cirrhosis. Hepatology. 1998;27(2):339–45.

    Article  Google Scholar 

  90. Franco RA, Ashwathnarayan R, Deshpandee A, Knox J, Daniel J, Eastwood D, Franco J, Saeian K. The high prevalence of restless legs syndrome symptoms in liver disease in an academic-based hepatology practice. J Clin Sleep Med. 2008;4(1):45–9.

    Article  Google Scholar 

  91. Mostacci B, Ferlisi M, Baldi Antognini A, Sama C, Morelli C, Mondini S, Cirignotta F. Sleep disturbance and daytime sleepiness in patients with cirrhosis: a case control study. Neurol Sci. 2008;29(4):237–40.

    Article  Google Scholar 

  92. Schomerus H, Hamster W. Quality of life in cirrhotics with minimal hepatic encephalopathy. Metab Brain Dis. 2001;16:37–41.

    Article  CAS  Google Scholar 

  93. Prasad S, Dhiman RK, Duseja A, Chawla YK, Sharma A, Agarwal R. Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy. Hepatology. 2007;45(3):549–59.

    Article  Google Scholar 

  94. Liu Q, Duan ZP, Ha DK, Bengmark S, Kurtovic J, Riordan SM. Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology. 2004;39(5):1441–9.

    Article  Google Scholar 

  95. Watanabe A, Sakai T, Sato S, Imai F, Ohto M, Arakawa Y, Toda G, Kobayashi K, Muto Y, Tsujii T, Kawasaki H, Okita K, Tanikawa K, Fujiyama S, Shimada S. Clinical efficacy of lactulose in cirrhotic patients with and without subclinical hepatic encephalopathy. Hepatology. 1997;26(6):1410–4.

    Article  CAS  Google Scholar 

  96. Dhiman RK, Sawhney MS, Chawla YK, Das G, Ram S, Dilawari JB. Efficacy of lactulose in cirrhotic patients with subclinical hepatic encephalopathy. Dig Dis Sci. 2000;45(8):1549–52.

    Article  CAS  Google Scholar 

  97. Sidhu SS, Goyal O, Mishra BP, Sood A, Chhina RS, Soni RK. Rifaximin improves psychometric performance and health-related quality of life in patients with minimal hepatic encephalopathy (the RIME trial). Am J Gastroenterol. 2011;106(2):307–16.

    Article  CAS  Google Scholar 

  98. Bajaj JS, Heuman DM, Wade JB, Gibson DP, Saeian K, Wegelin JA, Hafeezullah M, Bell DE, Sterling RK, Stravitz RT, Fuchs M, Luketic V, Sanyal AJ. Rifaximin improves driving simulator performance in a randomized trial of patients with minimal hepatic encephalopathy. Gastroenterology. 2011;140(2):478–487.e1.

    Article  CAS  Google Scholar 

  99. Malaguarnera M, Greco F, Barone G, Gargante MP, Malaguarnera M, Toscano MA. Bifidobacterium longum with fructo-oligosaccharide (FOS) treatment in minimal hepatic encephalopathy: a randomized, double-blind, placebo-controlled study. Dig Dis Sci. 2007;52(11):3259–65.

    Article  Google Scholar 

  100. Bajaj JS, Saeian K, Christensen KM, Hafeezullah M, Varma RR, Franco J, Pleuss JA, Krakower G, Hoffmann RG, Binion DG. Probiotic yogurt for the treatment of minimal hepatic encephalopathy. Am J Gastroenterol. 2008;103(7):1707–15.

    Article  Google Scholar 

  101. Sharma P, Sharma BC, Puri V, Sarin SK. An open-label randomized controlled trial of lactulose and probiotics in the treatment of minimal hepatic encephalopathy. Eur J Gastroenterol Hepatol. 2008;20(6):506–11.

    Article  CAS  Google Scholar 

  102. Shukla S, Shukla A, Mehboob S, Guha S. Meta-analysis: the effects of gut flora modulation using prebiotics, probiotics and synbiotics on minimal hepatic encephalopathy. Aliment Pharmacol Ther. 2011;33(6):662–71.

    Article  CAS  Google Scholar 

  103. McGee RG, Bakens A, Wiley K, Riordan SM, Webster AC. Probiotics for patients with hepatic encephalopathy. Cochrane Database Syst Rev. 2011;(11):CD008716. Update in: Cochrane Database Syst Rev. 2017 Feb 23;2:CD008716. PMID: 22071855

  104. Ryu AJ, Rahimi RS, Leise MD. The current hepatic encephalopathy pipeline. Review J Clin Exp Hepatol. 2020;10(4):377–85. Epub 2020 Jan 14.PMID: 32655239

    Article  Google Scholar 

  105. Ichinose M, Miura I, Horikoshi S, Matsumoto J, Osakabe Y, Yabe H. Memantine for behavioral symptoms of hepatic encephalopathy associated with alcoholic cirrhosis: a case report, Case Reports. J Clin Psychopharmacol. 2021;41(1):85–6. PMID: 33298741

    Article  Google Scholar 

  106. Harkness K, Demers C, Heckman GA, McKelvie RS. Screening for cognitive deficits using the Montreal cognitive assessment tool in outpatients ≥65 years of age with heart failure. Am J Cardiol. 2011;107(8):1203–7.

    Article  Google Scholar 

  107. Mapelli D, Bardi L, Mojoli M, Volpe B, Gerosa G, Amodio P, Daliento L. Neuropsychological profile in a large group of heart transplant candidates. PLoS One. 2011;6(12):e28313. Epub 2011 Dec 13

    Article  CAS  Google Scholar 

  108. Bhat G, Yost G, Mahoney E. Cognitive function and left ventricular assist device implantation. J Heart Lung Transplant. 2015;34(11):1398–405.

    Article  Google Scholar 

  109. Etgen T, Chonchol M, Förstl H, Sander D. Chronic kidney disease and cognitive impairment: a systematic review and meta-analysis. Am J Nephrol. 2012;35(5):474–82.

    Article  Google Scholar 

  110. Rakowski DA, Caillard S, Agodoa LY, Abbott KC. Dementia as a predictor of mortality in dialysis patients. Clin J Am Soc Nephrol. 2006;1(5):1000–5.

    Article  Google Scholar 

  111. Moss AH. Revised dialysis clinical practice guideline promotes more informed decision-making. Clin J Am Soc Nephrol. 2010;5(12):2380–3.

    Article  Google Scholar 

  112. Paraizo Mde A, Almeida AL, Pires LA, Abrita RS, Crivellari MH, Pereira Bdos S, Fernandes NM, Bastos MG. Montreal cognitive assessment (MoCA) screening mild cognitive impairment in patients with chronic kidney disease (CKD) pre-dialysis. J Bras Nefrol. 2016;38(1):31–41.

    Google Scholar 

  113. Cukor D, Rosenthal DS, Jindal RM, Brown CD, Kimmel PL. Depression is an important contributor to low medication adherence in hemodialyzed patients and transplant recipients. Kidney Int. 2009;75(11):1223–9.

    Article  Google Scholar 

  114. Kovacs AZ, Molnar MZ, Szeifert L, Ambrus C, Molnar-Varga M, Szentkiralyi A, Mucsi I, Novak M. Sleep disorders, depressive symptoms and health-related quality of life–a cross-sectional comparison between kidney transplant recipients and waitlisted patients on maintenance dialysis. Nephrol Dial Transplant. 2011;26(3):1058–65.

    Article  Google Scholar 

  115. von der Lippe N, Waldum B, Brekke FB, Amro AA, Reisæter AV, Os I. From dialysis to transplantation: a 5-year longitudinal study on self-reported quality of life. BMC Nephrol. 2014;15:191.

    Article  Google Scholar 

  116. Liaveri PG, Dikeos D, Ilias I, Lygkoni EP, Boletis IN, Skalioti C, Paparrigopoulos T. Quality of sleep in renal transplant recipients and patients on hemodialysis. J Psychosom Res. 2017;93:96–101.

    Article  Google Scholar 

  117. Goedendorp MM, Hoitsma AJ, Bloot L, Bleijenberg G, Knoop H. Severe fatigue after kidney transplantation: a highly prevalent, disabling and multifactorial symptom. Transpl Int. 2013;26(10):1007–15.

    Article  Google Scholar 

  118. Gross CR, Kreitzer MJ, Thomas W, Reilly-Spong M, Cramer-Bornemann M, Nyman JA, Frazier P, Ibrahim HN. Mindfulness-based stress reduction for solid organ transplant recipients: a randomized controlled trial. Altern Ther Health Med. 2010;16(5):30–8.

    Google Scholar 

  119. Burkhalter H, Wirz-Justice A, Denhaerynck K, Fehr T, Steiger J, Venzin RM, Cajochen C, Weaver TE, De Geest S. The effect of bright light therapy on sleep and circadian rhythms in renal transplant recipients: a pilot randomized, multicentre wait-list controlled trial. Transpl Int. 2015;28(1):59–70.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry, Memorial Regional Hospital, Hollywood, FL, USA

    Jorge Luis Sotelo & Alejandro Enrique Rodulfo

Authors
  1. Jorge Luis Sotelo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alejandro Enrique Rodulfo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jorge Luis Sotelo .

Editor information

Editors and Affiliations

  1. Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA

    Paula C. Zimbrean

  2. Department of Psychiatry, Stanford University School of Medicine, Stanford, CA, USA

    Yelizaveta Sher

  3. Department of Behavioral Health, Inova Fairfax Hospital, George Washington University, Falls Church, VA, USA

    Catherine Crone

  4. Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA

    Andrea F. DiMartini

Rights and permissions

Reprints and permissions

Copyright information

© 2022 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Sotelo, J.L., Rodulfo, A.E. (2022). Cognitive Impairment in the Pre-Transplant Setting. In: Zimbrean, P.C., Sher, Y., Crone, C., DiMartini, A.F. (eds) Transplant Psychiatry. Springer, Cham. https://doi.org/10.1007/978-3-031-15052-4_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-15052-4_13

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-15051-7

  • Online ISBN: 978-3-031-15052-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation